Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis

Table 3 Cases per million for increasing vaccination coverage levels (ages 12 and up, and 5 and up), with and without moderate NPIs. Vaccine with 88% efficacy assumed for all ages. R₀ =6.0. Median value of 100 simulations presented

Cases		Total	0–12 years	13–24 years	25–44 years	45–64 years	65–79 years	80y+
No NPIs	70% 12+	212,676	67,404	29,831	46,467	43,853	17,480	7589
	70% 5+	184,781	42,533	29,487	45,412	42,966	17,026	7372
	80% 12+	164,123	63,021	21,026	33,165	30,391	11,514	4985
	80% 5+	130,063	34,751	20,252	31,058	28,707	10,694	4583
	90% 12+	114,306	57,750	11,773	19,413	16,791	5962	2547
	90% 5+	65,119	21,972	9401	14,585	12,881	4381	1869
Moderate NPIs	70% 12+	167,682	58,849	24,250	37,429	32,826	10,116	4107
	70% 5+	129,998	31,373	22,789	33,274	29,880	8992	3632
	80% 12+	112,083	49,915	13,918	22,350	18,474	5233	2114
	80% 5+	58,322	16,791	9973	14,465	12,422	3356	1319
	90% 12+	64,646	39,580	5361	9813	7200	1906	759
	90% 5+	158	50	18	35	28	8	2

ISSN: 1741-7015